✦ LIBER ✦

Beta-2 adrenergic agonists: focus on safety and benefits versus risks

✍ Scribed by Victor E Ortega; Stephen P Peters

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Beta-3 versus beta-2 adrenergic agonists

✍ Michael C. Dennedy; Anne M. Friel; Francois Gardeil; John J. Morrison 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

Beta-3 versus beta-2 adrenergic agonists

✍ Michael C Dennedy; Anne M Friel; Francois Gardeil; John J Morrison 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Focus on Inhaled β2-Agonists: Efficacy,

✍ Roy A. Pleasants 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 321 KB

Effectiveness and safety of the oxytocin

📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB

Effectiveness and safety of the oxytocin

✍ The Worldwide Atosiban versus Beta-agonists Study Group Participants are listed 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

Effectiveness and safety of the oxytocin

📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 148 KB